Table 1. Published papers of phase III randomised single agent fluoropyrimidine-based chemoradiation documenting pCR.

Trial	Patient numbers	Chemo	RT Dose	pCR	OS
NSABP RO3, Roh 2009 (27)	267	FUFA	45 Gy/25#/33 days	17%	5 year 74%
CA0/ARO/AIO-94 (Sauer 2004) (28)	394	120 hour 5-FU infusion	50.4 Gy/28#/38 days	8%	4 year 74%
Polish study Bujko 2004, Bujko 2006 (29,30)	157	FUFA	50 Gy/25#/33 days	16%	4 year 66%
FFCD 9203 (Gerard 2006) (31)	375	FUFA	45 Gy/25#/33 days	11.4%	5 year 66%
EORTC 22921 (Bosset 2005,2006) (25,32)	505	FUFA	45 Gy/25#/33 days	13.4%	5 year 65%
All	1,698			211/1,698 (12.4%)